Trials / Completed
CompletedNCT00330616
Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
Clinical Evaluation of Bupropion SR (323U66)in Patients With Depression - Investigation in Elderly Patients With Depression
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to obtain clinical experience of 323U66 SR for elderly patients with depression in repeat-dose of 323U66 SR up to 300mg/day, and to conduct exploratory investigation on safety, efficacy and pharmacokinetics profile in elderly patients with depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 323U66 SR |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2007-11-01
- Completion
- 2007-11-01
- First posted
- 2006-05-29
- Last updated
- 2015-05-04
- Results posted
- 2009-03-20
Locations
9 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00330616. Inclusion in this directory is not an endorsement.